News

Antipsychotics’ risk in dementia revised upward


 

AT THE AAGP ANNUAL MEETING

Dr. Maust’s study was sponsored by the National Institute of Mental Health and the University of Michigan Program for Positive Aging. He reported having no financial conflicts, as did Dr. Lee, whose study was unfunded.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

USPSTF: Evidence still ‘insufficient’ to back cognitive impairment screening
MDedge Neurology
Late-life depression can be dementia prodrome
MDedge Neurology
Say goodbye to ‘dementia’
MDedge Neurology
ECT quells dementia-associated agitation
MDedge Neurology
Autism starts in utero, brain tissue study indicates
MDedge Neurology
Simple smell test may predict donepezil response
MDedge Neurology
Plasma Biomarker Panel May Predict Amnestic MCI or Alzheimer’s Disease
MDedge Neurology
Alzheimer’s Disease Mortality Rate Is Higher Than Reported
MDedge Neurology
Evidence May Be Insufficient to Support Cognitive Impairment Screening
MDedge Neurology
Human brain mapping project begins to reveal roots of developmental abnormalities
MDedge Neurology